Cardiovascular MRI, with its unceasing technological advances, allows in vivo imaging of a beating heart and a pulsatile artery with unparalleled anatomical coverage and contrast. The combination of MRI acquisitions with advanced image processing methods, allows for quantitative and multiparametric analysis of the central cardiocirculatory system, providing precise measurement of its geometry and function as well as its tissue and metabolic characteristics. The alteration of these MRI biomarkers at a very early stage, even before symptoms, favors their applicability in diabetic cardiomyopathy. Indeed, the ability of MRI to comprehensively and quantitatively explore aortic stiffness, global and regional myocardial strain, lipid deposits, along with its capacity to reveal unrecognized myocardial damage, enhance its usefulness for individual risk reclassification in patients with diabetes.